Pharvaris N.V. (PHVS) stock
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$31.55−0.73 (-2.26%)
Close on Nov 18, 2026Market cap $2.06BP/E –Yield –
Pharvaris free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -€137.24M. The highest annual figure on record is -€3.92M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€137.24M | – |
| FY2024 | Dec 31, 2024 | -€120.67M | – |
| FY2023 | Dec 31, 2023 | -€93.14M | – |
| FY2022 | Dec 31, 2022 | -€67.29M | – |
| FY2021 | Dec 31, 2021 | -€44.73M | – |
| FY2020 | Dec 31, 2020 | -€21.54M | – |
| FY2019 | Dec 31, 2019 | -€6.69M | – |
| FY2018 | Dec 31, 2018 | -€3.92M | – |
See a number that looks wrong?